Omeprazole and Drospirenone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Drospirenone (drospirenone). Common drug interactions include abortion missed among females.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Drospirenone. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Drospirenone?

Drospirenone has active ingredients of drospirenone. eHealthMe is studying from 603 Drospirenone users. Check the latest studies of Drospirenone.

On Aug, 10, 2026

15 people who take Omeprazole and Drospirenone together, and have interactions are studied.

Omeprazole and Drospirenone drug interactions.

What are the common drug interactions of Omeprazole and Drospirenone, by gender? *:

female:

Abortion missed (delayed or silent miscarriage)
Drug ineffective
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Death
Depression
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Drug effect decreased
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

male:

n/a

What are the common drug interactions of Omeprazole and Drospirenone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Haemorrhoid operation
Alopecia (absence of hair from areas of the body)
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

30-39:

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Fall
Fatigue (feeling of tiredness)
Gait disturbance
Muscular weakness (muscle weakness)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Neuralgia (pain in one or more nerves)

40-49:

Depression
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Nausea (feeling of having an urge to vomit)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Birth Control: 3 people, 20.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 20.00%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 3 people, 20.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 13.33%
Urinary Tract Infection: 1 person, 6.67%
Type 2 Diabetes: 1 person, 6.67%
Back Pain: 1 person, 6.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.67%
Diarrhea: 1 person, 6.67%
Drug Dependence: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Drospirenone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously